If you are experiencing problems downloading PDF or HTML fulltext, our helpdesk recommend clearing your browser cache and trying again. If you need help in clearing your cache, please click here . Still need help? Email help@ingentaconnect.com

Can we predict and prevent adult morbidity in males with childhood‐onset growth hormone deficiency?

$48.00 plus tax (Refund Policy)

Download / Buy Article:


In order to achieve an optimal quality of life and minimize morbidity in adulthood, the therapeutic management of patients with childhood‐onset growth hormone deficiency (GHD) should follow strict guidelines. Optimal final height should be obtained by the early diagnosis of GHD and subsequent adequate growth hormone (GH) dosing and duration of treatment. Moreover, particularly in males with associated gonadotrophin deficiency, the psychosexual maladjustment could be prevented by the earlier induction of puberty, completion of the male phenotype and testicular stimulation with gonadotropins or luteinizing hormone‐releasing hormone. Finally, a satisfactory peak bone mass could be attained by continuation of GH treatment for some years after cessation of linear growth. □ Childhood‐onset growth hormone deficiency, pubertal induction, quality of life, optimal peak bone mass

Document Type: Short Communication

DOI: http://dx.doi.org/10.1111/j.1651-2227.1997.tb18391.x

Publication date: November 1, 1997

Related content



Share Content

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more